Retatrutide
$150.00Price
Retatrutide is a triple agonist peptide that targets GLP-1, GIP, and glucagon receptors, primarily studied for metabolic and weight management applications.
Key research areas include:
Significant body weight reduction
Improvement of glycemic control and insulin sensitivity
Fat mass reduction and metabolic health
Potential effects on liver fat and cardiovascular markers
Treatment of obesity and type 2 diabetes
It is investigated as a next-generation incretin-based peptide with broader receptor activity than dual agonists like tirzepatide.
